Elsevier,
Antiviral Research, Volume 202, June 2022
Nelfinavir is an HIV protease inhibitor that has been widely prescribed as a component of highly active antiretroviral therapy, and has been reported to exert in vitro antiviral activity against SARS-CoV-2. We here assessed the effect of Nelfinavir in a SARS-CoV-2 infection model in hamsters.
Elsevier,
Tumour Virus Research, Volume 13, June 2022
This study explores provider preferences regarding anal cancer screening indications, initiation age, tools, and referral threshold to high resolution anoscopy (HRA). Although consensus was lacking with regard to specific screening initiation age, more respondents recommended younger initiation ages for men who have sex with men (MSM) living with HIV (LWH) compared with MSM not LWH (p
Elsevier,
The Lancet, Volume 399, 25 June 2022
This Article supports SDG 3 and 5 by exploring the indirect effects of COVID-19 on gender disparities globally, showing intensified levels of pre-existing widespread inequalities for a range of health, social, and economic indicators during the COVID-19 pandemic.
Elsevier,
iLIVER, Volume 1, Issue 2, June 2022, Pages 117-121
This study analyzed the clinical characteristics of patients with HEV-induced hemolytic anemia, finding a strong association with G6PD deficiency. Vaccinating individuals with G6PD deficiency is crucial to reduce the risk of this condition, aligning with the goal of ensuring good health and well-being for patients with hepatitis